Pre-eclampsia: pathophysiology and clinical implications.


Journal

BMJ (Clinical research ed.)
ISSN: 1756-1833
Titre abrégé: BMJ
Pays: England
ID NLM: 8900488

Informations de publication

Date de publication:
15 07 2019
Historique:
entrez: 17 7 2019
pubmed: 17 7 2019
medline: 20 7 2019
Statut: epublish

Résumé

Pre-eclampsia is a common disorder that particularly affects first pregnancies. The clinical presentation is highly variable but hypertension and proteinuria are usually seen. These systemic signs arise from soluble factors released from the placenta as a result of a response to stress of syncytiotrophoblast. There are two sub-types: early and late onset pre-eclampsia, with others almost certainly yet to be identified. Early onset pre-eclampsia arises owing to defective placentation, whilst late onset pre-eclampsia may center around interactions between normal senescence of the placenta and a maternal genetic predisposition to cardiovascular and metabolic disease. The causes, placental and maternal, vary among individuals. Recent research has focused on placental-uterine interactions in early pregnancy. The aim now is to translate these findings into new ways to predict, prevent, and treat pre-eclampsia.

Identifiants

pubmed: 31307997
doi: 10.1136/bmj.l2381
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

l2381

Informations de copyright

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Déclaration de conflit d'intérêts

Competing interests We have read and understood the BMJ policy on declaration of interests and declare the following interests: GJB, CR and AM, none. JMR is a consultant to Metabolomics Diagnostics Limited, a company attempting to develop a predictor of pre-eclampsia.

Auteurs

Graham J Burton (GJ)

Department of Physiology, Development & Neuroscience, University of Cambridge, UK.
Centre for Trophoblast Research, University of Cambridge, UK.

Christopher W Redman (CW)

Nuffield Department of Obstetrics and Gynaecology, University of Oxford, UK.

James M Roberts (JM)

Magee-Womens Research Institute, Depts. Obstetric Gynecology and Reproductive Sciences, Epidemiology, and Clinical and Translational Research, University of Pittsburgh, USA.

Ashley Moffett (A)

Centre for Trophoblast Research, University of Cambridge, UK am485@cam.ac.uk.
Dept of Pathology, University of Cambridge, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH